At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 186 enrolled
Drug / intervention
vigabatrin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
In Brief
A Phase 2 clinical trial evaluating vigabatrin and placebo for Cocaine Dependence. Completed, enrolled 186 participants across 11 sites.
Detailed Summary
The objective of this study is to demonstrate that a larger proportion of vigabatrin-treated subjects than placebo-treated subjects will be cocaine-free in the last 2 weeks of treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine Dependence
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2008
First PostedFeb 2008
Primary CompletionMay 2009
Study CompletionOct 2012
TodayJul 2026
First PostedFeb 8, 2008
Enrollment StartJan 1, 2008
Primary CompletionMay 1, 2009
Study CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 18.4 years ago
Interventions
vigabatrindrug
Tablets twice a day for 9 weeks
placebodrug
tablets twice daily for 9 weeks